XTL Biopharmaceuticals Ltd. (XTLB)
NASDAQ·Healthcare·Biotechnology
$2.30
-3.77%
Mkt Cap $956.38K
No analyst coverage available
We don't have analyst ratings or price target data for XTL Biopharmaceuticals Ltd. yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.